Medicaid smoking cessation programs with incentive-based interventions

Smoking Cessation Program

Smoking Cessation

Summarize how this project relates to the modules under review?

The impact and progression of a number of serious chronic diseases can be ameliorated by the lifestyle choices of people suffering from the diseases. Public health programs that facilitate positive lifestyle changes -- and actually help to bring about those changes -- are medically and economically important.

[This is a duplicate question -- see question item #1 above.)

5. Summarize how the data was collected and provide the baseline data of the performance level at the beginning of the project. Provide measureable data such as sample size, numerator, denominator etc. As applicable to the project. (use the measurement document overtime)?

Data collected from program participants includes saliva nicotine cotinine tests at two points: at three months and at six months after the conclusion of the study. Additional data was collected during focus groups and through the use of surveys sent to project participants. This mixed methods data collection and data analysis system produced both quantitative and qualitative data.

6. Provide sufficient information to substantiate what data will be collected and what methodologies will be used to provide for comparisons over time.

Members are selected for incentive plans through a randomization scheme. Plans must submit data to NYSDOH according to a specific protocol by way of the Health Commerce System (HCS). The plans are encouraged to submit timely data reports in order to facilitate dispersing the monetary incentives. That is to say, that a close temporal proximity (between one and three days) is preferred for the receipt of the data and the match-up mailing of the incentive to successful program participants.

7. Provide the measureable goals set by your organization

The measurable objectives for the organization include 2-year participation in the PIP project, with measures focused on participation in smoking cessation counseling and tobacco-dependence treatments, such as nicotine replacement therapy, Chantix, or Zyban, all of which result in fewer tobacco users overall and are supported by robust evidence from the U.S. Preventative Services Task Force.